TM6SF2 and metabolic dysfunction-associated steatotic liver disease: The TM6SF2 E167K variant also predisposes to progressive NAFLD by altering the secretion of very low-density lipoproteins25–27, but its direct role in HCC predisposition is disputed26, 28.